Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis.
<h4>Background</h4>Circulating immune cells including autoreactive T cells and monocytes have been documented as key players in maintaining, protecting and repairing the central nervous system (CNS) in health and disease. Here, we hypothesized that neurodegenerative diseases might be ass...
Guardado en:
Autores principales: | Ilan Vaknin, Gilad Kunis, Omer Miller, Oleg Butovsky, Shay Bukshpan, David R Beers, Jenny S Henkel, Eti Yoles, Stanley H Appel, Michal Schwartz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/229b39d1adf24f5281f19de1c1c36e4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani Majid, et al.
Publicado: (2021) -
Translational utility of experimental autoimmune encephalomyelitis: recent developments
por: Guerreiro-Cacais AO, et al.
Publicado: (2015) -
Testicular steroidogenesis is suppressed during experimental autoimmune encephalomyelitis in rats
por: Ana Milosevic, et al.
Publicado: (2021) -
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
por: M José Mansilla, et al.
Publicado: (2014) -
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Dhaiban S, et al.
Publicado: (2020)